Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Hall and Paul Shinn.
Matthew Hall
Connection Strength
0.700
Paul Shinn
  1. Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein. ACS Med Chem Lett. 2021 Aug 12; 12(8):1267-1274.
    View in: PubMed
    Score: 0.240
  2. Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay. ACS Pharmacol Transl Sci. 2020 Dec 11; 3(6):1352-1360.
    View in: PubMed
    Score: 0.228
  3. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci. 2021 Jun 11; 4(3):1124-1135.
    View in: PubMed
    Score: 0.059
  4. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
    View in: PubMed
    Score: 0.058
  5. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect Dis. 2021 06 11; 7(6):1389-1408.
    View in: PubMed
    Score: 0.057
  6. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. Mol Ther. 2021 02 03; 29(2):873-885.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.